EMD-27767

Single-particle
3.18 Å
EMD-27767
3D View Gallery
Deposition: 02/08/2022
Map released: 31/05/2023
Last modified: 14/05/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-27767

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-8dwy summary report (pdf.gz) Map-8dwy FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

Chikungunya VLP in complex with neutralizing Fab CHK-265 (asymmetric unit)

EMD-27767

Single-particle
3.18 Å
EMD-27767
3D View Gallery
Deposition: 02/08/2022
Map released: 31/05/2023
Last modified: 14/05/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Chikungunya virus strain Senegal 37997, Homo sapiens
Sample: Chikungunya VLP in complex with neutralizing Fab CHK-265 (asymmetric unit)
Fitted models: 8dwy

Deposition Authors: Adams LJ , Fremont DH
A chikungunya virus-like particle vaccine induces broadly neutralizing and protective antibodies against alphaviruses in humans.
Raju S , Adams LJ , Earnest JT , Warfield K , Vang L , Crowe Jr JE , Fremont DH , Diamond MS
(2023) Sci Transl Med , 15 , eade8273 - eade8273
PUBMED: 37196061
DOI: doi:10.1126/scitranslmed.ade8273
ISSN: 1946-6242